On May 31, 2021 Aequus Pharmaceuticals (AQS.V) reported financial results for Q1, 2021. Aequus is a $19 million pharmaceutical company focused on developing and commercializing high quality, differentiated…
Investing in dry eyes
Aequus is a $24 million pharmaceutical company focused on developing and commercializing high quality, differentiated products….